{
    "2021-08-15": [
        [
            {
                "time": "2021-08-15",
                "original_text": "【华西医药崔文亮团队】《长春高新点评报告：2021年上半年业绩增长符合预期，生长激素持续高增长》",
                "features": {
                    "keywords": [
                        "长春高新",
                        "2021年上半年",
                        "业绩增长",
                        "生长激素",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "知名药企，解散清算 减资破产",
                "features": {
                    "keywords": [
                        "知名药企",
                        "解散清算",
                        "减资破产"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "长春高新（000661）2021年中报点评：金赛业绩持续超预期，静待政策落地【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "长春高新",
                        "金赛",
                        "业绩超预期",
                        "政策落地"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "东吴证券维持长春高新买入评级：金赛业绩持续超预期，静待政策落地",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "长春高新",
                        "买入评级",
                        "金赛",
                        "业绩超预期",
                        "政策落地"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "华西证券维持长春高新买入评级：2021年上半年业绩增长符合预期，生长激素持续高增长",
                "features": {
                    "keywords": [
                        "华西证券",
                        "长春高新",
                        "买入评级",
                        "2021年上半年",
                        "业绩增长",
                        "生长激素",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "巴菲特潜在心动A股名单：未来净利高增长股仅11只",
                "features": {
                    "keywords": [
                        "巴菲特",
                        "A股",
                        "净利高增长",
                        "11只"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-15",
                "original_text": "陆家嘴财经早餐2021年8月15日星期日",
                "features": {
                    "keywords": [
                        "陆家嘴财经早餐",
                        "2021年8月15日"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}